02/12/2026
RSV continues to pose a serious risk to infants in Tennessee and across the country. Associate Professor of Pediatrics Christopher Keefer, M.D. explains why FDA-approved RSV immunizations are a game-changer, offering powerful protection for our youngest and most vulnerable patients.
Read his op-ed: https://www.williamsonherald.com/opinion/columns/commentary-rsv-puts-infants-at-risk-prevention-can-save-lives-this-winter/article_74bf530b-2d9b-44f6-b8b7-d5eda86e33df.html
American Academy of Pediatrics Meharry Medical College Wellpoint Nashville General Hospital CDC U.S. Department of Health and Human Services